Net Income (Loss) Attributable to Parent in USD of Apyx Medical Corp from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Apyx Medical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2025.
  • Apyx Medical Corp Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$1.98M, a 57.8% increase year-over-year.
  • Apyx Medical Corp Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$14.5M, a 48.9% increase year-over-year.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$23.5M, a 25.4% decline from 2023.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$18.7M, a 19.3% increase from 2022.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$23.2M, a 52.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Apyx Medical Corp Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$14.5M -$1.98M +$2.72M +57.8% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$17.3M -$3.78M +$2.78M +42.4% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$20M -$4.15M +$3.43M +45.2% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$23.5M -$4.63M +$4.98M +51.8% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 -$28.4M -$4.7M -$74K -1.6% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$28.4M -$6.56M -$5.56M -560% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$22.8M -$7.58M -$4.09M -118% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$18.7M -$9.61M -$3.56M -58.8% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 -$15.2M -$4.63M +$1.14M +19.7% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 -$16.3M -$994K +$4.43M +81.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$20.7M -$3.48M +$2.46M +41.4% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$23.2M -$6.05M -$4.05M -202% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$19.1M -$5.76M -$1.54M -36.5% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$17.6M -$5.43M -$1.38M -34.1% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 -$16.2M -$5.95M -$1.04M -21.3% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$15.2M -$2M -$476K -31.2% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 -$14.7M -$4.22M -$494K -13.3% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$14.2M -$4.05M +$644K +13.7% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$14.8M -$4.9M -$2.95M -151% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$11.9M -$1.53M +$3.86M +71.7% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 -$15.8M -$3.73M +$642K +14.7% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$16.4M -$4.69M -$352K -8.11% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$16M -$1.95M +$3.66M +65.2% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q4 2019 -$19.7M -$5.39M -$3.51M -187% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$16.2M -$4.37M -$72.8M -106% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $56.6M -$4.34M -$1.4M -47.7% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $58M -$5.61M -$4.67M -500% 01 Jan 2019 31 Mar 2019 10-Q/A 08 May 2020
Q4 2018 $62.7M -$1.88M -$1.05M -128% 01 Oct 2018 31 Dec 2018 10-K 31 Mar 2020
Q3 2018 $63.8M $68.5M +$69.7M 01 Jul 2018 30 Sep 2018 10-Q/A 08 May 2020
Q2 2018 -$5.94M -$2.94M -$1.63M -125% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 -$4.31M -$935K +$750K +44.5% 01 Jan 2018 31 Mar 2018 10-Q/A 08 May 2020
Q4 2017 -$5.06M -$824K +$7.3M +89.9% 01 Oct 2017 31 Dec 2017 10-K 31 Mar 2020
Q3 2017 -$12.4M -$1.25M -$280K -29% 01 Jul 2017 30 Sep 2017 10-Q/A 08 May 2020
Q2 2017 -$12.1M -$1.31M -$789K -152% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 -$11.3M -$1.69M +$259K +13.3% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$11.6M -$8.12M -$6.71M -476% 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019
Q3 2016 -$4.84M -$965K +$622K +39.2% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017
Q2 2016 -$5.46M -$519K +$978K +65.3% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017
Q1 2016 -$6.44M -$1.94M -$1.07M -122% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$5.37M -$1.41M +$4.04M +74.1% 01 Oct 2015 31 Dec 2015 10-K 18 Mar 2016
Q3 2015 -$9.41M -$1.59M +$1.39M +46.7% 01 Jul 2015 30 Sep 2015 10-Q 27 Oct 2016
Q2 2015 -$10.8M -$1.5M -$1.53M -5262% 01 Apr 2015 30 Jun 2015 10-Q 02 Aug 2016
Q1 2015 -$9.28M -$876K +$8.94M +91.1% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016
Q4 2014 -$18.2M -$5.45M -$329K -6.42% 01 Oct 2014 31 Dec 2014 10-K 18 Mar 2016
Q3 2014 -$17.9M -$2.98M -$2.64M -773% 01 Jul 2014 30 Sep 2014 10-K 18 Mar 2016
Q2 2014 -$15.2M $29K +$1.15M 01 Apr 2014 30 Jun 2014 10-K 18 Mar 2016
Q1 2014 -$16.4M -$9.81M -$9.4M -2299% 01 Jan 2014 31 Mar 2014 10-K 18 Mar 2016
Q4 2013 -$6.99M -$5.13M -$5.41M -1898% 01 Oct 2013 31 Dec 2013 10-K 27 Feb 2015
Q3 2013 -$1.58M -$341K -$334K -4771% 01 Jul 2013 30 Sep 2013 10-K 27 Feb 2015
Q2 2013 -$1.25M -$1.12M -$1.27M -836% 01 Apr 2013 30 Jun 2013 10-K 27 Feb 2015
Q1 2013 $21K -$409K -$596K -319% 01 Jan 2013 31 Mar 2013 10-K 27 Feb 2015
Q4 2012 $617K $285K +$1.16M 01 Oct 2012 31 Dec 2012 10-K/A 08 May 2014
Q3 2012 -$543K -$7K -$70K -111% 01 Jul 2012 30 Sep 2012 10-K/A 08 May 2014
Q2 2012 -$473K $152K -$277K -64.6% 01 Apr 2012 30 Jun 2012 10-K/A 08 May 2014
Q1 2012 -$196K $187K -$305K -62% 01 Jan 2012 31 Mar 2012 10-K/A 08 May 2014
Q4 2011 $109K -$875K 01 Oct 2011 31 Dec 2011 10-K 01 Apr 2013
Q3 2011 $63K +$59K 01 Jul 2011 30 Sep 2011 10-K 01 Apr 2013
Q2 2011 $429K +$373K +666% 01 Apr 2011 30 Jun 2011 10-K 01 Apr 2013
Q1 2011 $492K 01 Jan 2011 31 Mar 2011 10-K 01 Apr 2013
Q3 2010 $4K* 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 $56K 01 Apr 2010 30 Jun 2010 10-Q 12 Aug 2011

Apyx Medical Corp Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$23.5M -$4.75M -25.4% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 -$18.7M +$4.47M +19.3% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 -$23.2M -$8.01M -52.8% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$15.2M -$3.28M -27.5% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 -$11.9M +$7.81M +39.6% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 -$19.7M -$82.4M -131% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 $62.7M +$67.8M 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2020
2017 -$5.06M +$6.49M +56.2% 01 Jan 2017 31 Dec 2017 10-K 31 Mar 2020
2016 -$11.6M -$6.18M -115% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 -$5.37M +$11.9M +68.9% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018
2014 -$17.3M -$12.9M -298% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 -$4.34M -$4.96M -803% 01 Jan 2013 31 Dec 2013 10-K 18 Mar 2016
2012 $617K +$508K +466% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 $109K +$1.64M 01 Jan 2011 31 Dec 2011 10-K/A 08 May 2014
2010 -$1.54M 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.